🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Phase III main study is a randomized, controlled, multicenter, double b...
Status
Completed
Location
Beijing Tongren Hospital
Start Date
2022-10-23
Trial ID
NCT05629390
Treatments Being Tested
A Phase 1, Open-Label, Randomized, Single-Dose, Parallel-Group Study to Eva...
Status
Completed
Location
Dr. Vince Clinical Research
Start Date
2023-01-19
Trial ID
NCT05720364
This is a Phase 2a, randomized, double-blind, proof-of-concept, single-cent...
Status
Completed
Location
Tufts University School of Medicine
Start Date
2022-12-12
Trial ID
NCT05387083
Treatments Being Tested
Pharmacokinetic Study to Evaluate the Whole Blood Pharmacokinetics of TP-03...
Status
Completed
Location
Altasciences
Start Date
2021-02-09
Trial ID
NCT05138861
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and pharmacoki...
Status
Active Not Recruiting
Location
Study Site
Start Date
2026-03-09
Trial ID
NCT07562087
Treatments Being Tested
This is a Phase 1b, single-cente, randomized, double-blind, placebo-control...
Status
Not Yet Recruiting
Location
Malaria Research and Training Center
Start Date
2026-08
Trial ID
NCT07758985
This study is being done to evaluate the safety, tolerability, and efficacy...
Status
Completed
Location
The Centre for Clinical Trials
Start Date
2023-03-01
Trial ID
NCT05838170
Treatments Being Tested
The purpose of this study is to evaluate and compare the effect of two dosi...
Status
Unknown
Location
Shultz Chang Vision
Start Date
2023-08-01
Trial ID
NCT06054217
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of TP-03, 0...
Status
Completed
Location
Mitchell C. Shultz, MD
Start Date
2022-08-03
Trial ID
NCT05454956
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of TP-03, a...
Status
Completed
Location
Global Retina Institute
Start Date
2021-04-29
Trial ID
NCT04784091
Treatments Being Tested